CN Stock MarketDetailed Quotes

002275 Guilin Sanjin Pharmaceutical

Watchlist
  • 12.58
  • +0.05+0.40%
Market Closed Jul 12 15:00 CST
7.39BMarket Cap21.00P/E (TTM)

Guilin Sanjin Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Guilin Sanjin Pharmaceutical Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

482.59M

-32.59%
EPS(YoY)

0.17

-41.38%
Analyst Rating

Strong Buy

Jul 14, 2024

Guilin Sanjin Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/FY2.172B / 2.296B--
DatePeriodRevenue/EstimateEarnings Call
--2023/FY2.172B / 2.296B--

Guilin Sanjin Pharmaceutical Earnings Reports

  • Guilin Sanjin Pharmaceutical: 2024 FIRST QUARTER REPORT (CORRECTED)

    Apr 26 12:00 ET

  • Guilin Sanjin Pharmaceutical: Corrections to the 2024 First Quarter Report

    Apr 26 12:00 ET

  • Guilin Sanjin Pharmaceutical: 2024 First Quarter Report

    Apr 25 12:00 ET

  • Guilin Sanjin Pharmaceutical: 2023 Annual Report Summary

    Apr 25 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 14, 2024

    Strong Buy

    • Strong Buy

      60.00%

    • Buy

      40.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    %Chg